The story of Viagra, and its parent company copyright, presents a complex case study for investors. Originally a blockbuster drug, yielding billions in revenue , its intellectual property lapse created a flood of knock-off medications, significantly eroding its dominance. While certain pharmaceutical companies may try to capitalize on male sexual d